A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration.

Pharmacogenet Genomics · 2016 · PMC4890827 · PMID 26426212

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendP =0.06so close (0.05 < p ≤ 0.1)

The type of choroidal neovascularization showed a trend towards statistical significance ( P =0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.